Parkinsonism & Related Disorders
Volume 16, Issue 7 , Pages 438-441 , August 2010

Lingual protrusion dystonia: Frequency, etiology and botulinum toxin therapy

Received 10 March 2010 ,Accepted 19 April 2010.

References 

  1. Baik JS, Park JH, Kim JY. Primary lingual dystonia induced by speaking. Mov Disord. 2004;19:1251–1252
  2. Ishii K, Tamaoka A, Shoji S. A case of primary focal lingual dystonia induced by speaking. Eur J Neurol. 2001;8:507
  3. Tan EK, Chan LL. Sensory tricks and treatment in primary lingual dystonia. Mov Disord. 2005;20:388
  4. Schneider SA, Aggarwal A, Bhatt M, Dupont E, Tisch S, Limousin P, et al. Severe tongue protrusion dystonia: clinical syndromes and possible treatment. Neurology. 2006;67:940–943
  5. Marsden CD. Blepharospasm–oromandibular dystonia syndrome (Brueghel’s syndrome). A variant of adult-onset torsion dystonia?. J Neurol Neurosurg Psychiatry. 1976;39:1204–1209
  6. Tan EK, Jankovic J. Tardive and idiopathic oromandibular dystonia: a clinical comparison. J Neurol Neurosurg Psychiatry. 2000;68:186–190
  7. Hennings JM, Krause E, Botzel K, Wetter TC. Successful treatment of tardive lingual dystonia with botulinum toxin: case report and review of the literature. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:1167–1171
  8. Keane JR. Galloping tongue: post-traumatic, episodic, rhythmic movements. Neurology. 1984;34:251–252
  9. Ondo W. Lingual dystonia following electrical injury. Mov Disord. 1997;12:253
  10. Dabrowski E, Smathers SA, Ralstrom CS, Nigro MA, Leleszi JP. Botulinum toxin as a novel treatment for self-mutilation in Lesch–Nyhan syndrome. Dev Med Child Neurol. 2005;47:636–639
  11. Gollomp SM, Fahn S. Transient dystonia as a complication of varicella. J Neurol Neurosurg Psychiatry. 1987;50:1228–1229
  12. Greene P, Shale H, Fahn S. Analysis of open-label trials in torsion dystonia using high dosages of anticholinergics and other drugs. Mov Disord. 1988;3:46–60
  13. Jankovic J, Beach J. Long-term effects of tetrabenazine in hyperkinetic movement disorders. Neurology. 1997;48:358–362
  14. Klawans HL, Tanner CM. Cholinergic pharmacology of blepharospasm with oromandibular dystonia (Meige’s syndrome). Adv Neurol. 1988;49:443–450
  15. Soares KV, McGrath JJ. The treatment of tardive dyskinesia – a systematic review and meta-analysis. Schizophr Res. 1999;39:1–16
  16. Kenney C, Hunter C, Jankovic J. Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders. Mov Disord. 2007;22:193–197
  17. Ondo WG, Hanna PA, Jankovic J. Tetrabenazine treatment for tardive dyskinesia: assessment by randomized videotape protocol. Am J Psychiatry. 1999;156:1279–1281
  18. van Harten PN, Kahn RS. Tardive dystonia. Schizophr Bull. 1999;25:741–748
  19. Charles PD, Davis TL, Shannon KM, Hook MA, Warner JS. Tongue protrusion dystonia: treatment with botulinum toxin. South Med J. 1997;90:522–525
  20. Kasravi N, Jog MS. Botulinum toxin in the treatment of lingual movement disorders. Mov Disord. 2009;24:2199–2202
  21. Blitzer A, Brin MF, Fahn S. Botulinum toxin injections for lingual dystonia. Laryngoscope. 1991;101:799
  22. Hallett M, Benecke R, Blitzer A, Comella CL. Treatment of focal dystonias with botulinum neurotoxin. Toxicon. 2009;54:628–633
  23. Factor SA, Barron KD. Mosaic pattern of gliosis in the neostriatum of a North American man with craniocervical dystonia and parkinsonism. Mov Disord. 1997;12:783–789
  24. Lungu C, Aia PG, Shih LC, Esper CD, Factor SA, Tarsy D. Tardive dyskinesia due to aripiprazole: report of 2 cases. J Clin Psychopharmacol. 2009;29:185–186
  25. Schrag A, Bhatia KP, Quinn NP, Marsden CD. Atypical and typical cranial dystonia following dental procedures. Mov Disord. 1999;14:492–496
  26. Fahn S, Marsden CD, Calne DB. Classification and investigation of dystonia. In:  Marsden CD,  Fahn S editor. Movement disorders 2. London: Butterworths; 1987;p. 332–358
  27. Marsden CD. The focal dystonias. Clin Neuropharmacol. 1986;9(Suppl. 2):S49–S60
  28. Meige H. Les convulsion de la face, una forme clinique de convulsion faciale bilateral et mediane. Rev Neurol. 1910;21:437–443
  29. Tolosa E, Marti MJ. Blepharospasm–oromandibular dystonia syndrome (Meige’s syndrome): clinical aspects. Adv Neurol. 1988;49:73–84
  30. Tolosa ES, Klawans HL. Meiges disease: a clinical form of facial convulsion, bilateral and medial. Arch Neurol. 1979;36:635–637

☆ The review of this paper was entirely handled by an Associate Editor, Robert Rodnitzky.

PII: S1353-8020(10)00084-2

doi: 10.1016/j.parkreldis.2010.04.007

Parkinsonism & Related Disorders
Volume 16, Issue 7 , Pages 438-441 , August 2010

Article Tools

* Image Usage & Resolution